Advertisement

Topics

Novartis Announces Results From Study Of Patients In Entresto For Heart Failure

21:01 EST 12 Nov 2017 | FinanzNachrichten

BASEL (dpa-AFX) - Novartis announced new results from a real-world database study of patients in Germany prescribed Entresto (sacubitril/valsartan) for heart failure with reduced ejection fraction...

Original Article: Novartis Announces Results From Study Of Patients In Entresto For Heart Failure

NEXT ARTICLE

More From BioPortfolio on "Novartis Announces Results From Study Of Patients In Entresto For Heart Failure"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...